Catalyst Wire Dossier Catalyst Wire Dossier

Insulin lispro (novel formulation)

insulin lispro · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin lispro (novel formulation), covering 2017-07-13 to 2017-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps [Phase 1]

See pricing